首页> 美国卫生研究院文献>European Heart Journal. Acute Cardiovascular Care >Impact of TIMI 3 patency before primary percutaneous coronary intervention for ST-elevation myocardial infarction on clinical outcome: results from the ASSENT-4 PCI study
【2h】

Impact of TIMI 3 patency before primary percutaneous coronary intervention for ST-elevation myocardial infarction on clinical outcome: results from the ASSENT-4 PCI study

机译:STMI抬高型心肌梗死经皮冠状动脉介入治疗前TIMI 3通畅对临床结局的影响:ASSENT-4 PCI研究的结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background:Early restoration of blood flow of the infarct-related artery is associated with an improved outcome in patients with ST-elevation myocardial infarction (STEMI). Previous studies have shown a low mortality in patients with TIMI 3 flow before primary percutaneous coronary intervention (PCI). Most likely these patients had spontaneous recanalization of the infarct vessel and might constitute a low-risk subgroup. The purpose of the present analysis was to investigate whether TIMI 3 flow obtained with fibrinolysis before PCI is associated with a clinical outcome comparable to that in patients with spontaneous TIMI 3 flow.
机译:背景:梗死相关动脉的血流早期恢复与ST抬高型心肌梗死(STEMI)患者的转归改善有关。先前的研究表明,在进行初次经皮冠状动脉介入治疗(PCI)之前,TIMI 3血流患者的死亡率较低。这些患者最有可能自发梗塞血管再通,并且可能构成低风险亚组。本分析的目的是调查PCI之前通过纤溶作用获得的TIMI 3血流是否与可自发TIMI 3血流的患者的临床结果相媲美。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号